BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

CLDX upcoming catalysts

Celldex Therapeutics: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 4 readout(s) and 0 FDA event(s). Subscribe to CLDX (.ics).

Drugs: barzolvolimab

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
No FDA decision events in this window.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-08-12P3Celldex Therapeutics CLDXNCT06445023 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaChronic Spontaneous Urticariaactive not recruiting963
2026-08-04P3Celldex Therapeutics CLDXNCT06455202 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)Chronic Spontaneous Urticariaactive not recruiting976
2026-05-06P2Celldex Therapeutics CLDXNCT06727552 A Study of Barzolvolimab in Patients With Atopic DermatitisAtopic Dermatitisactive not recruiting131
2026-03-17P2Celldex Therapeutics CLDXNCT06366750 A Study of Barzolvolimab in Patients With Prurigo NodularisPrurigo Nodularisactive not recruiting140

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.